KYNU
Basic information
Region (hg38): 2:142877657-143055833
Links
Phenotypes
GenCC
Source:
- encephalopathy due to hydroxykynureninuria (Limited), mode of inheritance: AR
- vertebral, cardiac, renal, and limb defects syndrome 2 (Limited), mode of inheritance: AR
- encephalopathy due to hydroxykynureninuria (Supportive), mode of inheritance: AR
- congenital vertebral-cardiac-renal anomalies syndrome (Supportive), mode of inheritance: AR
- vertebral, cardiac, renal, and limb defects syndrome 2 (Strong), mode of inheritance: AR
- encephalopathy due to hydroxykynureninuria (Strong), mode of inheritance: AR
- vertebral, cardiac, renal, and limb defects syndrome 2 (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Vertebral, cardiac, renal, and limb defects syndrome 2 | AR | Cardiovascular | The condition can involve congenital cardiac anomalies, and awareness may allow early identifcation and management | Biochemical; Cardiovascular; Musculoskeletal; Renal | 17334708; 28792876; 34200361 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (57 variants)
- not_provided (28 variants)
- Vertebral,_cardiac,_renal,_and_limb_defects_syndrome_2 (17 variants)
- Congenital_NAD_deficiency_disorder (9 variants)
- KYNU-related_disorder (6 variants)
- Hydroxykynureninuria (4 variants)
- Catel-Manzke_syndrome (3 variants)
- Intellectual_disability (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KYNU gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003937.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 10 | |||||
| missense | 62 | 73 | ||||
| nonsense | 4 | |||||
| start loss | 0 | |||||
| frameshift | 6 | |||||
| splice donor/acceptor (+/-2bp) | 7 | |||||
| Total | 11 | 13 | 64 | 7 | 5 |
Highest pathogenic variant AF is 0.00015750766
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| KYNU | protein_coding | protein_coding | ENST00000264170 | 13 | 164824 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 4.18e-18 | 0.00552 | 125573 | 0 | 175 | 125748 | 0.000696 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.413 | 267 | 249 | 1.07 | 0.0000126 | 3032 |
| Missense in Polyphen | 93 | 95.641 | 0.97239 | 1068 | ||
| Synonymous | 0.829 | 79 | 88.9 | 0.888 | 0.00000456 | 878 |
| Loss of Function | 0.0902 | 27 | 27.5 | 0.981 | 0.00000151 | 333 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00116 | 0.00114 |
| Ashkenazi Jewish | 0.000332 | 0.000298 |
| East Asian | 0.000654 | 0.000653 |
| Finnish | 0.000382 | 0.000370 |
| European (Non-Finnish) | 0.00102 | 0.000976 |
| Middle Eastern | 0.000654 | 0.000653 |
| South Asian | 0.000498 | 0.000457 |
| Other | 0.000859 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the cleavage of L-kynurenine (L-Kyn) and L-3- hydroxykynurenine (L-3OHKyn) into anthranilic acid (AA) and 3- hydroxyanthranilic acid (3-OHAA), respectively. Has a preference for the L-3-hydroxy form. Also has cysteine-conjugate-beta-lyase activity. {ECO:0000269|PubMed:11985583, ECO:0000269|PubMed:17300176, ECO:0000269|PubMed:28792876, ECO:0000269|PubMed:8706755, ECO:0000269|PubMed:9180257}.;
- Disease
- DISEASE: Hydroxykynureninuria (HYXKY) [MIM:236800]: An inborn error of amino acid metabolism characterized by massive urinary excretion of large amounts of kynurenine, 3-hydroxykynurenine and xanthurenic acid. Affected individuals manifest renal tubular dysfunction, metabolic acidosis, psychomotor retardation, non- progressive encephalopathy, and muscular hypertonia. {ECO:0000269|PubMed:17334708, ECO:0000269|PubMed:28792876}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Vertebral, cardiac, renal, and limb defects syndrome 2 (VCRL2) [MIM:617661]: An autosomal recessive congenital malformation syndrome characterized by vertebral segmentation abnormalities, congenital cardiac defects, renal defects, and distal mild limb defects. {ECO:0000269|PubMed:28792876}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Tryptophan metabolism - Homo sapiens (human);Tryptophan Metabolism;Selenium Micronutrient Network;NAD Biosynthesis II (from tryptophan);Tryptophan metabolism;Tryptophan catabolism;Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism;Metabolism of amino acids and derivatives;tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde;Metabolism;L-kynurenine degradation;NAD <i>de novo</i> biosynthesis;Tryptophan degradation;superpathway of tryptophan utilization;tryptophan degradation
(Consensus)
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.539
- rvis_EVS
- -0.6
- rvis_percentile_EVS
- 18.06
Haploinsufficiency Scores
- pHI
- 0.0582
- hipred
- N
- hipred_score
- 0.204
- ghis
- 0.537
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.876
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Kynu
- Phenotype
Gene ontology
- Biological process
- tryptophan catabolic process;aging;NAD biosynthetic process;tryptophan catabolic process to kynurenine;tryptophan catabolic process to acetyl-CoA;quinolinate biosynthetic process;response to interferon-gamma;'de novo' NAD biosynthetic process from tryptophan;response to vitamin B6;anthranilate metabolic process;L-kynurenine catabolic process
- Cellular component
- nucleoplasm;mitochondrion;cytosol
- Molecular function
- pyridoxal phosphate binding;kynureninase activity;protein homodimerization activity;3-hydroxykynureninase activity